120841
胰高血糖素樣肽2/GLP-2 Peptide
序列號(hào)：146-178
純化方法：HPLC
產(chǎn)品應(yīng)用：Biological activity
Immunology research
Quantity size:
0.5mg
Source:
Synthetic Peptide
Form:
lyophilized powde
Purity:
≥95% (Purified by HPLC)
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
Biological activity
Immunology research
Background:
The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon. [provided by RefSeq].
GLP-2 stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.
具體產(chǎn)品信息請(qǐng)來電或在線咨詢。
上海華壹生物科技有限公司
Shanghai HuaYi Bio-technology Co.,Ltd
更多多肽介紹：胰高血糖素樣肽2/GLP-2 Peptide
| 載脂蛋白A1抗原/apoA1 (Apolipoprotein/APOA1 protein )human |
| 凝聚素α/β抗原/Apo J/Clusterin- Alpha/ Beta(Apolipoprotein J) |
| 胰島素受體-α（抗原）/Insulin Receptor-Alpha(ISR-Alpha) |
| 胰島素受體-α（抗原）/Insulin Receptor-Alpha(ISR-Alpha) |
| 胰島素受體-β（抗原）/Insulin Receptor- Beta(ISR- Beta) |
| 胰島素受體底物-1（抗原）/IRS-1 |
| 水通道蛋白-3抗原/AQP3(aquaporin 3) |
| 胰島素受體底物-2（抗原）/IRS-2 |
| 水通道蛋白-1抗原/AQP1(Aquaporin1) |
| 胰島素受體底物-3（抗原）/IRS-3 |
| 胰島素受體底物-4（抗原）/IRS-4 |
| 水通道蛋白-5抗原/AQP5(aquaporin Protein-5) |
| IRS P53 (Insulin receptor substrate P53)(多肽) |
| 前列腺素E2抗原/PGE2 peptide |
| 整合素-β3（抗原）/Integrin Beta chain (ITG- Beta3/ITGB3) |
| AQP9(aquaporin Protein-9) 水通道蛋白-9抗原 (多肽抗原) |
| 瘦素（多肽抗原）/Leptin |
| 瘦素受體（長(zhǎng)）（抗原）/Leptin receptor(long) |
| 雄激素受體（多肽）/phospho-AR/androgen receptor( p-Ser580)peptide |
| 絲裂原活化蛋白激酶（抗原）/MAPK-1/2 |
| 絲裂原活化蛋白激酶激酶/MAPKK2 |
| 丙酮酸激酶-M2（抗原）/M2-PK ( pyruvate Kinase M2) |
| 丙酮酸激酶-M2（抗原）/M2-PK ( pyruvate Kinase M2) |
| 磷酸化Rho鳥苷酸交換因子2抗原/p-Arhgef2/GEF-H1(Rho guanine nucleotide exchange factor 2,pSer810) |
| 黑色素-A（抗原）/Melan-A/MART-1 |
| 激活素受體2A/激活素受體相互作用蛋白2a抗原/ARIP2a(Activin receptor 2A) |
| β-抑制蛋白1/2抗原/Beta-arrestin 1/2(beta-arrestin 1/2) |
| ARIP2B(Activin receptor 2B) 激活素受體2B/激活素受體相互作用蛋白2b抗體 |
| 褪黑素受體（抗原）/MTR-1A (Melatonin receptor-1A) |
| MTLC (c-Myc target from laryngeal cancer cells)又稱：MYC 致癌基因（抗原） |
| 核受體輔助抑制因子（抗原）/N-coR1 (Nuclear receptor co-repressor 1) |
| 巢蛋白（神經(jīng)上皮干細(xì)胞蛋白）（抗原）/Nestin |
| α1腎上腺素能受體抗原/AR Alpha1( Alpha1-adrenergic receptor) |
| 脂肪炎癥因子Apelin36/Apelin36 |
| 巢蛋白（神經(jīng)上皮干細(xì)胞蛋白）（抗原）/Nestin |
| 神經(jīng)母細(xì)胞特異性轉(zhuǎn)移因子抗原/ASCL1/MASH1(Achaete-scute homolog 1) |
| ASPP1(apoptosis stimulating protein of P53 1) p53凋亡刺激蛋白1抗原 |
| P53凋亡刺激蛋白2抗原/ASPP2(apoptosis stimulating protein of P53 2) |
| 神經(jīng)束蛋白-155/neurofasciu-155 |
| 神經(jīng)生長(zhǎng)因子-β(多肽片斷抗原)/NGF- Beta |
| 血管緊張素I抗原/Ang I/AT1(Angiotensin I) |
| 神經(jīng)生長(zhǎng)因子受體（抗原）/NGF-R(p75NTR) |
| 血管緊張素Ⅱ-1型受體抗原/AT1R(Angiotensin II Type 1 Receptor) |
| 血管緊張素Ⅱ-1型受體抗原/AT1R/AGTR1(Angiotensin II Type 1 Receptor) |
| NFkB誘導(dǎo)的激酶（抗原）/NIK，NF-kappaB-Inducing Kinase |
| 活化復(fù)制因子1/ATF1 (Activating Transcription Factor1) |
| 神經(jīng)激肽B（抗原）/NKB (Neurokinins B) |
| 活化復(fù)制因子2（多肽）/ATF2 (Activating Transcription Factor2) |
| phospho-ATF2(pSer490/pSer498) 磷酸化活化復(fù)制因子2抗原 |
| 神經(jīng)激肽-B受體（抗原）/NKR ； Neurokin B receptor (Neuromedin K receptor; NK-4 receptor) |
